期刊选题

1、投稿方式：在线投稿。

2、刊内网址：http://www.tiprpress.com

http://www.sciencedirect.com/journal/chinese-herbal-medicines

http://www.tiprpress.com/chmen/ch/index.aspx

http://www.elsevier.com/locate/chmed

https://mc03.manuscriptcentral.com/chm（投稿系统）

3、出刊日期：季刊，逢季首月18日出版。

2022年8月30日星期二

《中草药（英文版）》作者须知Instruction for Authors

【2022年01期信息】

Chinese

Herbal Medicines (CHM) is an official international journal sponsored

by Tianjin Institute of Pharmaceutical Research and Institute of

Medicinal Plant Development, Chinese Academy of Medical Sciences. The

purpose of CHM is to provide a forum for the studies on Chinese herbal

medicines, phytomedicines, and natural products as well. The journal

will accept the following contributions: letters, original articles,

review papers, short communications, book reviews, conference

announcements, information, etc. The journal involves the studies on

active ingredients and complex formulations of herbal medicines in

medicinal resource, phytochemistry, pharmacology, toxicology,

pharmacokinetics, and therapeutic function by experiment and clinical

trials. It is the interest of this journal to introduce the latest

development in pharmaceutical sciences to readers.

1. Submission of manuscripts

Authors

could submit their manuscripts through online submission

http://mc03.manuscriptcentral.com/chm. The following should be complied

with: typing on one side only, size of character 12 point,

double-spaced, consecutive numbering of the pages. The text should be in

Word document for Windows.

2. Structure of manuscripts

2.1. Title page

On

the title page, besides the paper title for which two or three words

may be too vague, but 14 or 15 words are unnecessary long, full names of

authors, academic or professional affiliations, complete address for

the corresponding author (including e-mail address and fax number) and

financial support should be included.

If

authors from different institutions are given, they must be assigned to

the corresponding institutions unambiguously (by using 1, 2, and 3,

etc.).

2.2. Abstract

The

paper should contain an abstract with 200–300 words in English. The

abstract should summarize the main points of the article. The structure

form of the abstract should consist of Objective (purpose of the study),

Methods (basic procedures), Results (final findings with main data),

and Conclusion (potential possibility on the result).

2.3. Key words

Please provide 5–8 words as key words which are separated with semicolons and should be arranged in alphabetical order.

The key words should represent the core content of the paper.

They are added to the journal’s annual index later and should be selfexplanatory.

2.4. Format of text

The format of article should be structured as follows:

1.

Introduction; 2. Materials and methods; 3. Results; 4. Discussion; 5.

Conclusion; 6. Acknowledgements (if necessary); 7. References. The

format of the review and original articles could be downloaded on

www.tiprpress.com.

2.5. Introduction

Abrief

explanation of the investigation purpose should be given taking into

consideration of the current state of knowledge and referring to the

required theoretical fundamentals.

2.6. Materials and methods

Explanation

of the study such as, group formation/stratification, interdisciplinary

studies, and experimental conditions, detailed information about the

volunteers/patients, particulars referring to the test drug as in the

summary including batch number and manufacturer; apparatuses and devices

indicating the names and domiciles of the manufacturers/suppliers in

the brackets; detailed information about the experimental animals

provided with a source or cell lines along with keeping culture

conditions; explanation of mathematical symbols and formulas; and

description of the statistical method used (referring to unpublished

programs or computer models is not sufficient) should be introduced.

Studies on human beings or animals must completely comply with the

pertinent legal provisions/guidelines. Clinical studies must meet the

requirements specified in the Declaration of Helsinki. The approval by

an ethics committee must be documented.

2.7. Results

Summarizing

the data collected and their statistical treatment. Including only

relevant data, but giving sufficient detail to justify your conclusions.

Use equations, figures, and tables only where II Chinese Herbal

Medicines necessary for clarity and brevity. Simul- taneous presentation

of the same results both in figures and tables should be avoided.

2.8. Discussion

To

avoid repeating results in this section, instead of providing an

interpretation of them, discussing their significance, drawing

conclusions, and emphasizing any new and important aspects especially in

relation to other current knowledge. In addition to outline any

shortcomings in your experiments. New hypotheses and recommendations

could be proposed. To end with a brief conclusion ought to relate to the

goal stated in the introduction. The findings may be compared with the

results from other studies (referring to the respective literature).

2.9. Conclusion

The

purpose of the conclusion section is to put the interpretation into the

context of the original problem. Do not repeat discussion points or

include irrelevant material. Your conclusions should be based on the

evidence presented.

2.10. Acknowledgements

This

should be included before references and kept concise. Those who are

involved in acknowledgments may briefly be: 1. contributors that do not

warrant author-ship; 2. technical helper; 3. material supporter.

2.11. References

Literatures

should be referred to by name and year (Harvard System) chronologically

at the end of the paper. Only texts that have been published or are in

press may be cited. Any other unpublished information, personal

communications or publication in preparation must not be cited. Authors

are responsible for the accuracy and completeness of the references.

In

the text, “et al” should be used for citations containing up to or more

than three authors, such as Martin et al, 1993. If more than one work

by the same authors appeared in one year, use lowercase letters to

identify and separate the references (e.g. Smith, 1989a; 1989b; 1989c).

In reference list entries, all authors must be listed. Journal articles

should be cited as follows: (1) names of all authors; (2) year of

publication; (3) title; (4) journal title; (5) volume number; (6) issue;

(7) inclusive page numbers.

Liu,

C. X., Xiao, P. G., Peng, Y., & Song, N. N. (2009). Challenges in

research and development of traditional Chinese medicines.

Liu, C. X., Xiao, P. G. (1992). Recent advances on ginseng research in China. Journal of Ethnopharmacology 36(5), 27-38.

For

books and thesis, list as: (1) author names; (2) year published; (3)

chapter title if appropriate; (4) book title, including edition number;

(5) place of publication; (6) publisher (7) volume number; (8) page

numbers if appropriate.

Emboden W. (1972). Norcotic Plants. London: Studio Vista, 24.

Hunssein, F. T. K. (1985). Salvia agyptiaca. In Medicinal Plants in Libya (pp. 311-312). Tripoli: Arab Encyclopaedia House.

Milton,

A. S. (1988). Prostaglandins and fever. In Sharma HS, Westman J,

editors. Progress in Brain Research; V.115 (pp. 129-139). Amsterdam:

Elsevier.

For

conference proceedings and conference papers, list as: (1) author name

(s) of all authors; (2) year published; (3) title; (4) name of

conference proceedings or conference paper collection; (5) year, month,

date, and place (country, city); (6) place of publication and publisher;

(7) volume number; (8) inclusive page numbers.

Wang,

L. C. (1987). Current drug safety testing in USA. Proccedings of

International Symposium on Traditional Medicines and Modern

Pharmacology; 1987 May 2-4 China, Chinese Pharmacological Society;

Beijing, 257-261.

For

patents, list as (1) applicant and owner; (2) title of patent; (3)

country; (4) patent No; (5) publication date; (6) access path.

Yamadaki,

M., Shimoyama, A. Angiotensin converting enzyme I inhibitor extraction

from the Eucommia ulmoides leaves. Patent of Japan Kokai Tokyo, Koho, JP

04368336. Abstract 1993: 118 (154549c) 457.

For organizations as authors, list as follow:

World

Health Organization. (1998). Good manufacturing practices for

pharmaceutical products. Annex 1.Thirty-second Report of the WHO Expert

Committee on Specifications for Pharmaceutical Preparation. WHO

Technical Report Series N.823. Geneva, Switzerland: World Health

Organization.

2.12. Corresponding author responsibilities

Serves

as the primary contact on behalf of all coauthors. Ensures that the

Conflict of Interest/Disclosure Section and the Acknowledgment Section

of the manuscript is complete and up-to-date for all authors. Includes

all persons who have contributed to the manuscript but are not authors

and obtains permission from each person listed in the Acknowledgment

section. If the paper is accepted for publication, obtains signatures

from all authors on the copyright transfer agreement. If an author is

not able to sign, then obtains their written permission to execute this

agreement on their behalf.

3. Illustration

3.1. Plant and animal names

All

official Latin names of plants (including Chinese herbal medicines),

animals, bacteria, and fungus must be italicized throughout the text and

full written in the first citing, then the appears below or in all

tables and figures, the genus name abbreviation with an abbreviation

point needs to be cited only for the plant, animal, bacteria, or fungus

name, etc. But the genus name in italics with the designation in block

letter should be written totally in every citing of the paper. e.g.

Cirsium setosum (Willd.) MB. Subsequent citings of the same name can be

abbreviated to: “C. setosum”; and the genus name shouled be Vallaris Burm. f.

3.2. Name of novel compound

The

trivial name of the novel compound should be given by the author except

the chemical name, e.g. charantadiol A

[5β,19-epoxycucurbita-6,23(E),25(26)- triene-3β,19(R)-diol].

3.3. Numbers

Use numerals with units of time or measure, and use a space between the numeral and the unit, except%and ◦ (angular degrees). e.g. 15 d, 9 h, 6 min, 25 mL, 0.30 g, 180◦C, but 50% and 180◦C, and

for all numbers greater than ten. With items other than units of time

or measure, use words for cardinal numbers less than 10, use numerals

for 10 and above. Spell out ordinals “first” through “ninth”,

use numerals for 10th or greater. e.g. three flasks, 30 flasks, third

flask, 12th flask, seven trees, and 10 trees. The exception is to use

all numerals in a series or range containing numbers 10 or greater, even

in non-technical text, e.g. 5, 8, and 12 experiments, 2nd and 20th

samples, 5-15 repetitions.While beginning a sentence the numbers should

be spelt out. When describing the units in a series of numbers, the use

of the omitted form is preferred, only the last needs to be kept, for

example 20, 40, and 60 mg/L (not 20 mg/L, 40 mg/L, and 60 mg/L); 20-60

mg/g (not 20 mg/g-60 mg/g), but the numberical percentage should be in

full form, for example, 20%–60% (not 20–60%). The measured data should

be consistent with the accuracy of the measuring instrument.

3.4. Abbreviations

Only

standard abbreviations, as listed in The ACS Style Guide may be used

without definition. Terms appearing frequently within a paper may be

abbreviated, but should be spelled out at first citation, with the

abbreviation following in parentheses. Examples: pharmacokinetics (PK),

ranitidine (Ran), ginseng saponin (GS), Ginkgo biloba extract (GbE),

volume of distribution (Vd), calcium calmodilin dependent protein kinase

(CCDPK).

3.5. Figures and tables

Figures:

All tables, figures and illustrations should be clearly legible. The

tables and figures (e.g., Table 1, Table 2, etc, Figure 1, Figure 2,

etc.) should be numbered consecutively as they appear in the text. Any

notes or legends should appear at the bottom of the table or figure.

Please be sure that the legend and notes enable the reader to understand

the table or figure without need for referencing the text of the

article. Each figure should be arranged and numbered consecutively with

all captions together. Characters of figures should still be easily

legible after the reduction in size. The size of symbols in curve

diagrams should be appropriate, too. Each axismust be provided with the

corresponding text and unit of measure. Encapsulated PostScript (EPS)

and bitmap files (halftone or photographic images) as Tagged Image

Format (TIFF), with a resolution of at least 300 dpi at final size. The

following are acceptable file types for figures: .tif, .jpg, .pdf, .ppt,

and .eps. Do not send native file formats. Colored figures are possible

on princeple. Moreover, the position of each figure should be marked

clearly in the manuscript following the narrative part of the paper.

Tables:

Each table should have a brief title and the position should be marked

obviously in the manuscript. Units of measure are to be indicated in the

head of the table. Each table should follow the paragraph in which they

are cited. If the table must exceed one page, duplicate all headings on

the second sheet. Number tables in the order. If data from any other

sources, published or unpublished, are used, obtain a permission letter

for their use and cite the source in the legend.

4. Review and publication process

Manuscripts

are examined by editor and in most cases by two reviewers. Any material

accepted for publication will be subject to copyediting. Authors will

receive page proofs and should answer all queries before publication,

and also carefully check all editorial changes at this point. The first

author of each article will receive two copies of issue. Additional

reprints and complete copies of the issue may be ordered directly from

the publisher.

5. Publishing conditions

Only

manuscripts that have not yet been published may be submitted. The

Copyright Transfer Statement is necessary. All researchers (authors),

reviewers, and editors must abide by the medical ethical obligation and

also must deter to the ethical obligation for publication. The authors

assure that they are solely entitled to exercise the right of

utilization in regard to their article including figures, tables, etc.,

if applicable, and that no rights of third parties are violated. The

authors themselves are responsible for the permission to reproduce

material previously published elsewhere, and sources must be

acknowledged. The corresponding author acts on behalf of all co-authors.

Authors are solely responsible for the contents of articles on

principle. Papers submitted for publication are subject to review by the

journal’s editorial advisory board. The editors inform the authors

about the results of the review process making suggestions for a

revision, if necessary. The publisher is entitled to permit any reprint

to the third parties without indemnification to the authors.

6. Copyright and publisher’s rights

All

articles published in the journal are protected by copyright. According

to Copyright Law of China, no part of this journal may be duplicated in

any form, distributed or otherwise exploited or transferred into a

machine-readable language or translated without prior consent in writing

from the publisher. In particular, electronic digitization, storage or

utilization by any means are prohibited.

Editorial office of CHM

Tel: +86-22-2300 6901

E-mail: chmtianjin@126.com

bjchmimplad@126.com

Website: www.tiprpress.com